GSK pays CureVac $430M for mRNA vaccines against flu and COVID—as partner lays off 30% 0 03.07.2024 11:43 Fiercebiotech.com GSK pays CureVac $430M for mRNA vaccines against flu and COVID—as partner lays off 30% ntaylor Wed, 07/03/2024 - 04:43
